10-Q: Ichor Holdings Reports Q3 Loss Amid Restructuring, Sales Up

Ichor Holdings, a key supplier to the semiconductor industry, reported a significant net loss in the third quarter of 2025 despite increased net sales, driven by substantial restructuring costs and inventory impairments.

Summary

• Net sales increased by 13.3% to $239.3 million for the three months ended September 26, 2025, and by 17.6% to $724.0 million for the nine months ended September 26, 2025, compared to the prior year periods.
• The company reported a net loss of $22.9 million ($0.67 per diluted share) for the three months ended September 26, 2025, a significant increase from a net loss of $2.8 million ($0.08 per diluted share) in the prior year period.
• For the nine months ended September 26, 2025, the net loss was $36.8 million ($1.08 per diluted share), compared to a net loss of $16.9 million ($0.52 per diluted share) in the prior year period.
• Gross profit decreased by 60.2% to $11.1 million in the three months ended September 26, 2025, with gross margin falling to 4.6% from 13.2% in the prior year, primarily due to $16.7 million in inventory write-off costs from the Consolidation Restructuring Plan.
• Operating loss widened to $19.4 million in the three months ended September 26, 2025, from $0.4 million in the prior year.
• Cash and cash equivalents decreased by $16.2 million to $92.5 million as of September 26, 2025, from $108.7 million at December 27, 2024.
• A Consolidation Restructuring Plan was approved in the third quarter of 2025, incurring $16.7 million in inventory impairment, $0.5 million in fixed asset charges, and $0.4 million in operating right-of-use asset impairment.
• An amended and restated credit agreement was entered into on September 26, 2025, including a $125.0 million term loan and a $100.0 million revolving credit facility.

Sentiment

Score: 3

Explanation: Despite increased sales, the company reported significantly wider net losses and declining gross margins due to substantial restructuring charges and inventory impairments. While non-GAAP metrics show some improvement, the GAAP results and cash flow trends indicate significant operational challenges and costs associated with strategic adjustments. The long-term industry outlook is positive, but current performance is weak.

Positives

• Net sales increased by 13.3% for the three months and 17.6% for the nine months ended September 26, 2025, driven by increased customer demand in the semiconductor capital equipment industry.
• Non-GAAP net income for the nine months ended September 26, 2025, increased to $7.6 million from $3.1 million in the prior year period.
• Non-GAAP diluted EPS for the nine months ended September 26, 2025, increased to $0.22 from $0.10 in the prior year period.
• The company successfully amended and restated its credit agreement, securing a $125.0 million term loan and a $100.0 million revolving credit facility, and was in compliance with debt covenants as of September 26, 2025.
• Weighted average borrowing rate decreased to 6.08% for the three months ended September 26, 2025, and 6.13% for the nine months ended September 26, 2025, from 7.23% and 7.43% respectively in the prior year periods.
• The company maintains confidence in the long-term demand for semiconductors and semiconductor capital equipment.

Negatives

• Reported a significant net loss of $22.9 million for the three months ended September 26, 2025, compared to a net loss of $2.8 million in the prior year.
• Reported a net loss of $36.8 million for the nine months ended September 26, 2025, compared to a net loss of $16.9 million in the prior year.
• Gross profit decreased by 60.2% for the three months and 12.5% for the nine months ended September 26, 2025, primarily due to substantial inventory write-off costs totaling $16.7 million from the Consolidation Restructuring Plan and $1.6 million from the Scotland/Korea exit.
• Operating loss significantly widened to $19.4 million for the three months and $25.4 million for the nine months ended September 26, 2025.
• Cash and cash equivalents decreased by $16.2 million from December 27, 2024, to September 26, 2025.
• Net cash provided by operating activities decreased to $20.7 million for the nine months ended September 26, 2025, from $30.4 million in the prior year.
• Net cash used in investing activities increased to $32.9 million for the nine months ended September 26, 2025, from $13.2 million in the prior year, primarily due to higher capital expenditures.
• Financing activities shifted from providing $19.4 million in cash in the prior year to using $4.0 million in the current nine-month period.
• Increased income tax expense due to Pillar Two minimum tax rules in Singapore and increased withholding taxes.

Risks

• Geopolitical, economic, and market conditions, including high inflation, changes to tax, trade, fiscal, and monetary policy, high interest rates, currency fluctuations, supply chain challenges, and disruptions from conflicts in Ukraine and the Middle East.
• Dependence on expenditures by manufacturers and cyclical downturns in the semiconductor capital equipment industry.
• Reliance on a very small number of original equipment manufacturers (OEMs) for a significant portion of sales.
• Inability to attract, hire, integrate, and retain key personnel and other necessary employees.
• Negotiating leverage held by customers.
• Competitiveness and rapid evolution of the industries in which the company participates.
• Challenges in keeping pace with developments in the industries served and with technological innovation generally.
• Difficulty in designing, developing, and introducing new products that are accepted by OEMs.
• Potential involvement in litigation and regulatory proceedings, leading to significant expense and business disruptions.
• Challenges in managing manufacturing and procurement processes effectively.
• Product defects that could damage reputation, decrease market acceptance, and result in costly litigation.
• Dependence on a limited number of suppliers.
• Uncertainty regarding the global trade environment, tariffs, and U.S. export controls, particularly those restricting China's access to advanced semiconductor technology, which could impact costs, prices, demand, and supply chain.
• The Consolidation Restructuring Plan is expected to incur additional expenses through the end of 2026, with potential for further unanticipated costs.
• The company is under examination by California tax authorities for fiscal years 2020-2022.

Future Outlook

Management anticipates overall semiconductor equipment spending in 2025 to grow over 2024 levels, particularly in the primary markets of etch and deposition, where current demand remains healthy. The company remains confident in the long-term demand for semiconductors, semiconductor capital equipment, and its products, driven by an increasing need for expanded productive capacity and advanced manufacturing process technologies.

Management Comments

• We remain confident in our belief that the long-term demand for semiconductors, semiconductor capital equipment, and our products will continue to grow, driven by an increasing need for expanded semiconductor productive capacity and advanced manufacturing process technologies.

Industry Context

The semiconductor capital equipment industry is inherently cyclical, but 2025 is anticipated to see growth over 2024 levels, especially in etch and deposition markets where demand is healthy. However, the industry faces ongoing uncertainties from the global trade environment, potential tariffs, and U.S. export controls aimed at restricting China's access to advanced semiconductor technology, which could impact demand, supply chains, and financial results. Ichor Holdings, as a key supplier of fluid delivery subsystems, is directly exposed to these dynamics.

Comparison to Industry Standards

• The semiconductor capital equipment industry is cyclical, and Ichor's performance is directly tied to this cycle. While the filing indicates anticipated industry growth in 2025, Ichor's GAAP net losses and declining gross margins suggest it is currently underperforming relative to a growth environment, likely due to internal restructuring costs.
• The company's reliance on a small number of OEMs is a common characteristic in specialized supplier segments of the semiconductor industry, similar to other component manufacturers like Entegris or MKS Instruments, which also face customer concentration risks.
• The restructuring plan, including inventory and asset impairments, indicates a strategic adjustment to optimize operations, a common practice for companies in cyclical industries during periods of market shifts or operational inefficiencies. Specific comparable projects or companies are not mentioned in the filing.

Corporate Governance

Legal Proceedings

• The company is currently under examination by California tax authorities for fiscal years 2020-2022.
• Neither the company nor any of its subsidiaries is a party to, and none of its respective property is the subject of, any legal proceeding that, if determined adversely, would have a material adverse effect on the company.

Stakeholder Impact

• Shareholders: Negative impact from significant net losses and decreased shareholder equity. Potential long-term benefits if restructuring improves profitability. Dilution risk from share-based compensation plans.
• Employees: Impacted by restructuring plans (e.g., Scotland operations exit, North America consolidation) which may involve severance costs and changes in employment. Benefits from 401(k) matching contributions and employee stock purchase plan.
• Customers: Continued supply of critical fluid delivery subsystems for semiconductor capital equipment. Potential for improved efficiency and product offerings post-restructuring.
• Suppliers: Potential impact from changes in procurement processes due to restructuring and consolidation.
• Creditors: The company remains in compliance with debt covenants, and the amended credit agreement provides a clear repayment schedule, which is positive for creditors.

Next Steps

• The Consolidation Restructuring Plan is expected to be substantially complete by the end of 2026, with additional expenses likely during periods after September 26, 2025.
• Quarterly term loan principal payments of $1.6 million commence on December 31, 2025.
• The company is evaluating the effect of new FASB ASUs on income tax disclosures (effective after December 15, 2024) and disaggregation of income statement expenses (effective after December 15, 2026).
• The tax holiday for Singapore operations is expiring in 2026.

Key Dates

Recommendation

The company reported a substantial increase in net losses and a significant decline in gross profit, primarily driven by large restructuring charges and inventory impairments. While sales increased, the underlying profitability issues and negative cash flow from operations and financing activities are concerning. The restructuring plan, while potentially beneficial long-term, introduces near-term uncertainty and costs. The overall financial health, as reflected in GAAP metrics, has deteriorated, suggesting a 'sell' recommendation until there is clear evidence of improved profitability and successful execution of the restructuring plan.

Keywords

semiconductor capital equipment, fluid delivery subsystems, gas delivery systems, chemical delivery systems, restructuring plan, inventory impairment, net loss, Q3 2025 earnings, ICHR, financial results, supply chain, export controls, debt refinancing, corporate governance